Medical News

RSS

FDA grants Pathway marketing clearance for JETSTREAM Navitus revascularization catheter for PVD

Pathway Medical Technologies, Inc, an innovator of endovascular treatments for peripheral vascular disease (PVD), announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market JETSTREAM Navitus, an enhanced revascularization catheter for the treatment of PVD.

6 Jun 2011

Incyte seeks FDA marketing approval of ruxolitinib for myelofibrosis

Incyte Corporation announced today that it has submitted a New Drug Application (NDA) for its lead investigational compound, ruxolitinib (INCB18424), to the US Food and Drug Administration (FDA).

6 Jun 2011

Roper acquires Northern Digital

Roper Industries, Inc. today announced that it has completed the previously announced acquisition of Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications.

6 Jun 2011

TenX BioPharma grants Emergent BioSolutions rights to zanolimumab

Emergent BioSolutions Inc. announced today that it has acquired from TenX BioPharma, Inc. the rights to zanolimumab, an investigational, late-stage monoclonal antibody cancer therapy targeting T-cell lymphomas.

6 Jun 2011

FDA grants 510(k) clearance to 3DISC for FireCR Medical Scanners and QuantorMed Imaging Software

3DISC, a manufacturer of high-quality, affordable computed radiography solutions, has received 510(k) clearance from the U.S. Food and Drug Administration to market its line of FireCR Medical Scanners and QuantorMed Imaging Software in the United States.

6 Jun 2011

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Adolor Corporation today announced that it has completed enrollment in its Phase 2 clinical evaluation of ADL5945 in chronic, non-cancer pain patients with opioid-induced constipation (OIC).

6 Jun 2011

FDA clears ArthroCare's Spartan 6.5 Needled Anchor

ArthroCare® Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan™ 6.5 Needled Anchor (Spartan). The Spartan device is a preloaded threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.

6 Jun 2011

Majority of Canadian parents concerned about sun protection for children, CDA survey

Almost all Canadian parents (92%) are concerned about sun protection for their children, a new survey for the Canadian Dermatology Association (CDA) shows.

6 Jun 2011

Bruker to introduce unique CaptiveSpray ion source for proteomics at ASMS 2011

At ASMS 2011, Bruker is introducing the breakthrough, proprietary CaptiveSpray electrospray ion source for nano-HPLC applications in proteomics. Using CaptiveSpray technology in many cases increases bottom-up protein identifications significantly, and CaptiveSpray is presently the best available technology for robust, reproducible protein ID or quantitative proteomics applications, with excellent, stable sensitivity over long time periods

6 Jun 2011

Ohio's Adena Health System chooses eClinicalWorks EHR solution for physicians

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Ohio's Adena Health System has chosen the eClinicalWorks comprehensive electronic health records (EHR) solution for its 150 employed physicians.

6 Jun 2011

Mazor Robotics introduces next-generation spinal surgical guidance system

Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, introduced today Renaissance, the next-generation of the world's only spinal robotic surgical guidance system.

6 Jun 2011

VHA honors Medical Action with 2011 service excellence award

Medical Action Industries Inc., a leading supplier of medical and disposable surgical products today announced that VHA Inc., the national health care network, honored Medical Action Industries as the Non-Pharmacy Supplier of the Year at its Annual Leadership Conference, May 15-17, in San Diego, Calif. Medical Action is a long-time supplier of Novation, VHA's health care supply contracting company.

6 Jun 2011

PING, HP partner to reduce malaria through mobile health monitoring technology

On the heels of the United Nations Social Innovation Summit, HP and nonprofit organization Positive Innovation for the Next Generation (PING) are launching a collaboration to improve the quality and efficiency of disease surveillance in Botswana through mobile health monitoring technology that can enhance protection and prevention against major malaria outbreaks.

6 Jun 2011

First Edition: June 6, 2011

Kaiser Health News staff writer Christopher Weaver reports: "Short on cash and time, officials in California and at least a dozen other states have turned to philanthropies to help pay for the extra work required under the federal health law".

6 Jun 2011

FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis

Aradigm Corporation today announced it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ciprofloxacin for inhalation for the management of bronchiectasis (BE).

6 Jun 2011

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.

6 Jun 2011

Constellation raises $15M in Series B extension financing

Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced that it has raised $15 million in a Series B extension financing. All major current investors participated in the round, including Third Rock Ventures, The Column Group, Venrock Associates, SR One and Altitude Life Science Ventures.

6 Jun 2011

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

Amylin Pharmaceuticals, Inc. today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy.

6 Jun 2011

New gene therapy may cure Type 1 diabetes

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of curing a disease that affects 3 million Americans.

6 Jun 2011

Light exposure can enhance brain's visual circuits

Any parent knows that newborns still have a lot of neurological work to do to attain fully acute vision. In a wide variety of nascent animals, genes provide them with only a rough wiring plan and then leave it to the developing nervous system to do its own finish work.

6 Jun 2011

Medical News

FDA grants Pathway marketing clearance for JETSTREAM Navitus revascularization catheter for PVD

Incyte seeks FDA marketing approval of ruxolitinib for myelofibrosis

Roper acquires Northern Digital

TenX BioPharma grants Emergent BioSolutions rights to zanolimumab

FDA grants 510(k) clearance to 3DISC for FireCR Medical Scanners and QuantorMed Imaging Software

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

FDA clears ArthroCare's Spartan 6.5 Needled Anchor

Majority of Canadian parents concerned about sun protection for children, CDA survey

Bruker to introduce unique CaptiveSpray ion source for proteomics at ASMS 2011

Ohio's Adena Health System chooses eClinicalWorks EHR solution for physicians

Mazor Robotics introduces next-generation spinal surgical guidance system

VHA honors Medical Action with 2011 service excellence award

PING, HP partner to reduce malaria through mobile health monitoring technology

First Edition: June 6, 2011

FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis

Positive data from Biogen Idec's AVONEX clinical trial on multiple sclerosis presented at CMSC 2011

Constellation raises $15M in Series B extension financing

Amylin's metreleptin clinical study data on partial lipodystrophy presented at ENDO 2011

New gene therapy may cure Type 1 diabetes

Light exposure can enhance brain's visual circuits

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News